Chandelier Cells

Chandelier Cells

Introduction

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Chandelier Cells</th>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:4023036](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_4023036)</td>
</tr>
<tr>
<td class="label">Database</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:4023036](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_4023036)</td>
</tr>
<tr>
<td class="label">Marker</td>
<td>Expression</td>
</tr>
<tr>
<td class="label">Parvalbumin (PV)</td>
<td>High</td>
</tr>
<tr>
<td class="label">Voltage-gated potassium channels (Kv1.1)</td>
<td>High</td>
</tr>
<tr>
<td class="label">GAT-1</td>
<td>High</td>
</tr>
<tr>
<td class="label">Neuropeptide Y</td>
<td>Variable</td>
</tr>
<tr>
<td class="label">Reelin</td>
<td>Present</td>
</tr>
<tr>
<td class="label">Gene</td>
<td>Expression Level</td>
</tr>
<tr>
<td class="label">PVALB</td>
<td>Very High</td>
</tr>
<tr>
<td class="label">GAD1/2</td>
<td>High</td>
</tr>
<tr>
<td class="label">GAT-3</td>
<td>High</td>
</tr>
<tr>
<td class="label">KCNA1</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">CNTNAP2</td>
<td>Moderate</td>

Chandelier Cells

Introduction

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Chandelier Cells</th>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:4023036](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_4023036)</td>
</tr>
<tr>
<td class="label">Database</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:4023036](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_4023036)</td>
</tr>
<tr>
<td class="label">Marker</td>
<td>Expression</td>
</tr>
<tr>
<td class="label">Parvalbumin (PV)</td>
<td>High</td>
</tr>
<tr>
<td class="label">Voltage-gated potassium channels (Kv1.1)</td>
<td>High</td>
</tr>
<tr>
<td class="label">GAT-1</td>
<td>High</td>
</tr>
<tr>
<td class="label">Neuropeptide Y</td>
<td>Variable</td>
</tr>
<tr>
<td class="label">Reelin</td>
<td>Present</td>
</tr>
<tr>
<td class="label">Gene</td>
<td>Expression Level</td>
</tr>
<tr>
<td class="label">PVALB</td>
<td>Very High</td>
</tr>
<tr>
<td class="label">GAD1/2</td>
<td>High</td>
</tr>
<tr>
<td class="label">GAT-3</td>
<td>High</td>
</tr>
<tr>
<td class="label">KCNA1</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">CNTNAP2</td>
<td>Moderate</td>
</tr>
</table>

Chandelier Cells is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Chandelier cells (ChCs), also known as axo-axonic cells, are a distinctive subtype of GABAergic interneurons characterized by their unique axonal morphology that forms synaptic contacts exclusively with the axon initial segments of pyramidal neurons. These cells play a critical role in regulating cortical circuit excitability and have emerged as increasingly relevant to understanding neurodegenerative diseases including Alzheimer's disease, epilepsy, and frontotemporal dementia. [@woodruff2019]

Overview

Chandelier cells represent one of the most morphologically specialized neuronal subtypes in the mammalian brain. Their name derives from the distinctive candle-holder-like appearance of their axonal terminals, which synapse onto the axon initial segment (AIS) of target pyramidal neurons. The AIS is the site where action potentials are generated, making ChCs powerful regulators of neuronal output . [@palop2016]

<!-- taxonomy-enrichment --> [@huang2019]

<!-- multi-taxonomy-enrichment --> [@rudy2021]

Multi-Taxonomy Classification

Taxonomy Database Cross-References

Morphology & Electrophysiology

• Morphology: pvalb chandelier GABAergic interneuron (source: Cell Ontology)
• Morphology can be inferred from Cell Ontology classification

External Database Links

• [Cell Ontology (CL:4023036)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_4023036)
• [OBO Foundry (CL:4023036)](http://purl.obolibrary.org/obo/CL_4023036)
• [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
• [CellxGene Census](https://cellxgene.cziscience.com/)
• [Human Cell Atlas](https://www.humancellatlas.org/)

Taxonomy & Classification

External Database Links

• [Cell Ontology (CL:4023036)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_4023036)
• [OBO Foundry (CL:4023036)](http://purl.obolibrary.org/obo/CL_4023036)
• [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
• [CellxGene Census](https://cellxgene.cziscience.com/)

Morphology and Markers

Structural Characteristics

Chandelier cells possess several defining morphological features:

• Axonal Arborization: The axonal plexus forms vertically oriented "cartridges" that target multiple pyramidal neuron AISs within a narrow columnar domain
• Axon Initial Segment Synapses: Form exclusive GABAergic synapses on the AIS, uniquely positioned to control action potential generation
• Dendritic Architecture: Dendrites typically extend horizontally and receive excitatory inputs from local pyramidal neurons and other interneurons
• Soma Location: Most commonly found in layers 2/3 and layer 5 of the cerebral cortex

Molecular Markers

Chandelier cells can be identified by the following molecular markers:

Normal Function in Neural Circuits

Inhibitory Control of Pyramidal Neurons

Chandelier cells provide powerful perisomatic inhibition through their exclusive targeting of pyramidal neuron AISs. This positioning allows them to :

Cortical Circuit Integration

Chandelier cells integrate into local cortical microcircuits through:

• Recurrent Inhibition: Receive excitatory inputs from nearby pyramidal neurons, creating feedback inhibition
• Disinhibition: Can be modulated by other interneurons, allowing flexible control of circuit activity
• Cross-laminar Communication: Connect neurons across cortical layers through their extensive axonal projections

Vulnerability in Disease

Alzheimer's Disease

Chandelier cells show significant vulnerability in Alzheimer's disease through multiple mechanisms :

• Pyramidal Neuron Loss: Loss of pyramidal neuron targets reduces ChC synaptic partners
• AIS Pathology: Hyperphosphorylated tau accumulates at the AIS, potentially disrupting ChC synapses
• Network Hyperexcitability: Reduced ChC-mediated inhibition may contribute to epileptiform activity in AD
• Impaired Gamma Oscillations: Loss of ChC function correlates with disrupted gamma rhythms and cognitive deficits

Epilepsy

Chandelier cells play a central role in epilepsy pathogenesis:

• Perisomatic Inhibition Loss: ChC dysfunction leads to disinhibition and hyperexcitability
• Pyramidal Neuron Hyperexcitability: Reduced AIS inhibition allows excessive firing
• Seizure Generation: Aberrant ChC activity patterns may initiate or propagate seizures
• Therapeutic Target: Restoring ChC function represents a potential anticonvulsant strategy

Frontotemporal Dementia

In FTD, chandelier cell pathology contributes to:

• Cortical Dysfunction: Loss of inhibitory control in frontal and temporal cortices
• Network Abnormalities: Disrupted excitation-inhibition balance
• Cognitive Deficits: Impaired gamma oscillations affecting attention and working memory

Schizophrenia and Related Disorders

While not neurodegenerative, ChC dysfunction is implicated in:

• Gamma Oscillation Deficits: Impaired 40 Hz auditory steady-state response
• Pyramidal Neuron Hyperactivity: Reduced perisomatic inhibition
• Cognitive Impairments: Working memory and attention deficits

Transcriptomic Profile

Single-cell transcriptomic studies have characterized the molecular signature of chandelier cells :

Enriched Genes

Differentially Expressed in Disease

• Reduced PV Expression: Early marker of ChC dysfunction
• Altered GABAergic Signaling: Dysregulation of inhibitory transmission genes
• Calcium Homeostasis Changes: Modified calcium buffering capacity

Therapeutic Implications

Target for Neurodegenerative Disease

Chandelier cells represent potential therapeutic targets for:

Epilepsy Treatment

Strategies targeting ChC function include:

• KV1.1 Modulators: Enhancing presynaptic inhibition
• GABA-A Receptor Agonists: Potentiating ChC-mediated inhibition
• Cell Replacement Therapy: Transplanting ChC progenitors

Background

The study of Chandelier Cells has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

Brain Atlas Resources

• [Allen Cell Type Atlas - PVALB](https://celltypes.brain-map.org/)
• [Allen Human Brain Atlas - Cell Type Data](https://human.brain-map.org/microarray)allen-human-brain-atlas)
• [Allen Mouse Brain Atlas](https://mouse.brain-map.org/)mouse-brain-atlas)
• [BrainSpan - Brain Development](https://brainspan.org/)

External Links

• [Allen Brain Atlas - Chandelier Cell Transcriptomics](https://portal.brain-map.org/atlases-and-data/rnaseq)
• [NIAAA - GABAergic Signaling in Neurodegeneration](https://www.niaaa.nih.gov/)neurodegeneration)
• [Society for Neuroscience - Interneuron Diversity](https://www.sfn.org/)